Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
846.1 INR | -2.85% | +2.25% | +30.32% |
May. 10 | Market Heavyweights Lifts Indian Equities to End Week Higher | MT |
May. 10 | Strides Pharma Arm Gets US FDA's Approval for Generic Drug for Hypocalcemia | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+30.32% | 961M | B | ||
+22.35% | 44.12B | B- | ||
+22.22% | 22.61B | B+ | ||
+17.96% | 15.11B | - | ||
+15.73% | 13.61B | B+ | ||
+57.91% | 13.34B | B | ||
-8.98% | 6.94B | B+ | ||
-0.05% | 6.79B | - | - | |
+15.65% | 5.75B | B+ | ||
-8.87% | 5.73B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- STAR Stock
- Ratings Strides Pharma Science Limited